Chemical Microarray for Systematic RNA-Ligand Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying RNA-ligand interactions are not systematic, limiting the rational design of drugs targeting RNA, as they do not allow for the simultaneous probing of RNA space and chemical space effectively.
Innovation Solution
A method involving immobilizing ligands on a support, contacting them with a nucleic acid motif library, and identifying bound motifs, which includes selecting ligands based on their binding affinity to specific nucleic acid motifs and their lack of binding to others, using techniques like chemical microarrays and click chemistry.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Extent of automation
If current methods (SELEX, SAR by MS/NMR, chemical microarrays) are used to study RNA-ligand interactions, then RNA-ligand interactions can be identified, but the study is not systematic because RNA space and chemical space are probed separately
Solution Approach 1:
The patent combines RNA motif libraries and ligand libraries into a single microarray format, allowing simultaneous probing of both RNA space and chemical space. RNA motifs are immobilized on the microarray surface, and ligands are applied in solution to identify binding interactions systematically across multiple RNA-ligand pairs in parallel.
Solution Approach 2:
The microarray platform serves multiple functions: it can screen diverse RNA motifs against diverse ligands, identify binding interactions, determine binding affinities, and characterize specificity profiles. This universal platform replaces multiple separate experimental approaches with a single integrated system.
2Adaptability or versatility
If RNA is used as a drug target, then diverse functions can be targeted (catalysis, gene regulation, etc.), but rational design is limited due to lack of information on RNA ligand interactions
Solution Approach 1:
The patent performs preliminary screening to identify which RNA motifs bind to which ligands before rational drug design begins. By pre-characterizing RNA-ligand interactions across diverse motifs and ligands, the method creates a knowledge base that informs subsequent rational design efforts, eliminating the information gap that currently limits RNA drug target development.
Solution Approach 2:
The systematic data generated from microarray screening provides feedback on RNA-ligand binding patterns, affinities, and specificities. This information feeds back into the drug design process, enabling rational optimization of ligands for specific RNA targets based on empirically determined interaction characteristics rather than trial-and-error approaches.
3Measurement precision
If ligands are screened against RNA motifs, then binding interactions can be identified, but selecting ligands with specificity (binding to one motif but not others) is challenging
Solution Approach 1:
The patent segments the screening process into individual RNA motif tests within the microarray format. Each RNA motif is immobilized at a distinct location, allowing ligands to be tested against multiple individual motifs simultaneously. This segmentation enables precise measurement of binding affinity for each motif while also revealing specificity patterns by comparing binding across different motifs.
Solution Approach 2:
The patent varies ligand concentration parameters to determine binding affinities and specificity. By testing ligands at multiple concentrations against different RNA motifs, the method identifies ligands that bind strongly to one motif but weakly or not at all to others, thereby characterizing and selecting for ligand specificity through parameter optimization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the systematic identification of RNA-ligand interactions, facilitating the design of molecules that target specific RNA motifs, potentially leading to more effective RNA-targeting drugs and probes.
Implementation Method 1
contacting the plurality of immobilized ligands with a nucleic acid motif library under conditions effective for one or more members of the nucleic acid motif library to bind with the immobilized ligands
Data Source
AI summary
Disclosed are methods for identifying a nucleic acid (e.g., RNA, DNA, etc.) motif which interacts with a ligand. The method includes providing a plurality of ligands immobilized on a support, wherein each particular ligand is immobilized at a discrete location on the support; contacting the plurality of immobilized ligands with a nucleic acid motif library under conditions effective for one or more members of the nucleic acid motif library to bind with the immobilized ligands; and identifying members of the nucleic acid motif library that are bound to a particular immobilized ligand. Also disclosed are methods for selecting, from a plurality of candidate ligands, one or more ligands that have increased likelihood of binding to a nucleic acid molecule comprising a particular nucleic acid motif, as well as methods for identifying a nucleic acid which interacts with a ligand.